Abrezekimab (Anti-IL-13)
Product Specifications
CAS Number
2043952-59-4
Synonyms
UCB4144; VR 942
SKU
C00256-1mg
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Abrezekimab (anti-IL-13) is a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. It can be used in research of asthma. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PDMH100369-01 20 µg
Recombinant Human SIGLEC2/CD22 Protein (His Tag)
Sign In for Pricing
View Details PDMH100369-02 100 µg
Recombinant Human SIGLEC2/CD22 Protein (His Tag)
Sign In for Pricing
View Details PDMH100369-03 500 µg
Recombinant Human SIGLEC2/CD22 Protein (His Tag)
Sign In for Pricing
View Details PDMH100369-04 1 mg
Recombinant Human SIGLEC2/CD22 Protein (His Tag)
Sign In for Pricing
View Details 
BNC402862-500 1x 500 µL
HLA-DP (MHC II) (HLA-DPB1/2862R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details